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ABSTRACT A review was made of the records of all patients with pulmonary tuberculosis and diabetes
mellitus admitted over a 5-year period to a teaching hospital in Karachi, Pakistan. Among 42 358 pattients, the total number with both tuberculosis and diabetes was 173. The prevalence of tuberculosis in
diabetic patients was 10-times higher than in non-diabetic patients and prevalence increased with durattion of diabetes. The lower lung field was most frequently involved, followed by the upper and middle.
Bilateral involvement was seen in half and an associated pleural effusion in one-third of the patients.
Cavitating lesions were seen in 32% of men and 15% of women.
Caractéristiques cliniques de la tuberculose pulmonaire chez des patients adultes pakistanais
présentant une comorbidité de diabète sucré
RÉSUMÉ On a procédé à un examen des dossiers de tous les patients atteints de tuberculose pulmmonaire et de diabète sucré qui ont été admis dans un hôpital universitaire de Karachi (Pakistan) sur
une période de 5 ans. Sur les 42 358 patients, le nombre total de patients atteints à la fois de tubercullose et de diabète s’élevait à 173. La prévalence de la tuberculose chez les patients diabétiques était
10 fois plus élevée que chez les patients non diabétiques et la prévalence augmentait avec la durée du
diabète. Le champ pulmonaire inférieur était le plus fréquemment atteint, suivi par le champ supérieur
et moyen. On a noté une atteinte bilatérale chez la moitié des patients et un épanchement pleural
associé chez un tiers des patients. Des lésions cavitaires ont été observées chez 32 % des hommes
et 15 % des femmes.
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Introduction
Pulmonary tuberculosis (TB) and diabett
tes mellitus (DM) may coexist frequently,
particularly in a population at high risk of
acquiring TB. DM has been reported to
modify the clinical features of TB. Compt
parative studies of TB in diabetics have
provided conflicting results. In a recent
study from Mexico, diabetic patients were
older, had more lower lung field lesions
and had more multiple cavities [1]. In a
Turkish study, DM did not affect the prest
senting features of pulmonary TB and was
only associated with more lower lung field
disease in females and in older patients [2].
Another study from Saudi Arabia showed
similar symptoms, radiographic distribution
and cavitary disease in diabetic and nondiabetic patients with pulmonary TB [3].
Pulmonary TB may adversely affect
glycaemic control. TB infection has been
shown to produce glucose intolerance that
improves or normalizes with anti-TB treatmt
ment [4]. This association is not specific to
TB but is seen in other respiratory infections
such as pneumonia [5]. Asian patients from
the Indian subcontinent have a higher incidt
dence of insulin resistance and associated
complications [6]. There is little information
on whether DM affects the presentation,
radiographic manifestations and clinical
course of pulmonary TB for Asian patients
from the Indian subcontinent.
The aims of this study were to determt
mine whether DM alters the clinical and
radiographic manifestations of pulmonary
TB in Pakistani patients and to compare the
prevalence of TB in hospitalized patients
with and without DM.

Methods
The study was a retrospective descriptive
study conducted at The Aga Khan Universt
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sity Hospital, a 450-bed teaching hospital
in Karachi, Pakistan. The medical records
were reviewed for all adult patients (aged
14 years and above) with a diagnosis of both
pulmonary TB and DM, admitted from Janut
uary 1992 to December 1996. Information
about demographic data, clinical features,
laboratory investigations and outcome of
treatment were recorded.
Patients with diabetes were included if
they had a previous history of DM and were
receiving anti-diabetic therapy at the time
of hospital admission or were later found to
have 2 or more fasting blood glucose levels
greater than 140 mg/dL and started on antidiabetic treatment. An age- and sex-matched
group of non-diabetic patients, who were
hospitalized during the same time period,
were used as the control group to estimate
the prevalence of TB in non-diabetics.
The diagnosis of TB was based on a posit
itive culture or histopathology, a suggestive
serosal fluid report or typical radiographic
findings with high clinical probability of
TB. The data on radiographic findings were
collected using the posterior–anterior roentgt
genograms obtained at the time of diagnost
sis. In compliance with the usual clinical
approach, the upper, mid and lower zones
were defined by theoretical horizontal lines
passing at the level of the anterior ends of
the second and fourth ribs, respectively.
Statistical analysis (including prevalt
lence rates) was performed using Epi-Info
statistical software, version 6.0. Student’s
t-test or chi-squared test were performed
where applicable.

Results
A total of 42 358 patients were admitted to
The Aga Khan University Hospital, between
1992 and 1996. The number of patients disct
charged with a diagnosis of DM was 1458
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and with a diagnosis of TB was 691. The
total number of patients with both TB and
DM were 173. The prevalence of TB in
diabetic patients was 173/1458 (11.9%) and
in non-diabetic patients was 691/40 900
(1.7%) (P < 0.5).
Data on 93 of the 173 patients (56 males,
37 females) with both TB and DM was availat
able for analysis. The clinical characteristics
of these patients are presented in Table 1.
The majority of the patients (82%) were
40–70 years of age, with only 6% below 40
years and 12% above 70 years of age. The
prevalence of TB increased progressively
with the duration of DM (Table 1).
The highest prevalence was in those with
DM of more than 10 years duration. Most of
the patients (80%) required oral hypoglyct
caemic agents and hence were classified as

type 2 diabetics; about 9% required insulin
and the remainder were diet-controlled.
Fever was the commonest presenting
symptom of TB in this group, being high
grade (> 38 ºC) in 55% of patients and
of more than 3-months duration in 10%
of patients. Positive auscultatory findings
on chest examination were found in 84%,
with bronchial breathing in 13%. We found
43.0% of lower lobe, 20.3% upper lobe and
only 15.0% middle lobe involvement on
clinical examination.
Chest radiograph findings are presented
in Table 2 for the 77 patients for whom
chest X-rays were available (some X-rays
were unavailable for analysis as patients
had been allowed to take the films). The
lower lung fields were most frequently
involved, followed by the upper and middle
fields. Cavitating lesions were significantly
more common in males (32%) than in femt
males (15%). Erythrocyte sedimentation

Table 1 Clinical characteristics of pulmonary
tuberculosis (TB) patients with diabetes
mellitus (n = 93)    
Characteristic

Value

Patient characteristics
Male: female ratio
Mean (range) age (years)
Mean (range) duration of
diabetes (years)

Table 2 Chest radiograph findings in
pulmonary tuberculosis patients with
diabetes mellitus (n = 77)   

3:2
46.1

(20–90)

13.8

(1–17)

                No.

%

Duration of diabetes (years)
<2
2–5
5–10
>10

6
14
26
47

7
15
28
51

Family history of tuberculosis
Yes

10

11

Presenting symptoms of TB
Fever
Cough
Dyspnoea
Haemoptysis
Weight loss

67
61
22
17
8

72
66
24
18
9

Variable

No.

%

Side affected
Right
Left
Bilateral

31
10
36

40
13
47

Lung field affected
Upper only
Middle only
Lower only
Upper and middle
Upper, middle and lower
Upper and lower
Middle and lower

12
10
24
9
1
5
6

18
15
36
13
1
7
9

Associated features
Effusion
Cavity
Hilar lymphadenopathy

25
20
4

32
26
5
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rate (ESR) was checked in 61 patients and
was < 100 mm/h in only 13 patients. Pleural
biopsy was performed in 13/25 patients
with pleural effusion and was diagnostic in
11 patients.
The number of patients who died was 10
overall, giving a mortality rate in these 93
patients with DM and TB of 11%. Mortalit
ity was not influenced by the radiographic
appearance. A high ESR (> 50 mm/h) was
associated with a better outcome. The mean
ESR for patients who died was 46 mm/h
compared with 76 mm/h for patients who
were cured.
The outcome of anti-TB therapy was
better in type 1 DM, when compared with
type 2 DM with early clearance of bacilli
and improvement in cavities: after 6 months
5/9 (56%) patients with type 1 DM showed
clearance of bacilli compared with 32/84
(40%) patients with type 2 DM.

Discussion
Our study describes the characteristics of
pulmonary TB in Pakistani adult diabetics
with a diagnosis of both TB and DM. In
our hospitalized patients, TB prevalence
was 11.9% in patients with DM, 10-times
more common than in those without DM.
In a large cohort of Korean diabetic patients
(over 8000) the relative risk of developit
ing bacteriological confirmed pulmonary
TB was 5 times higher in diabetics than in
matched controls [6]. In a random sample
of 100 Indian diabetic patients, TB was
diagnosed by a positive sputum result in
6% and by radiological examination in 27%
[7]. In a 1–7 year follow-up study of 1250
African diabetic patients, 5.4% developed
pulmonary TB [8]. The prevalence was
higher in those with a lower body mass
index, in type 1 DM compared with type 2
DM and in those whose diabetes was poorly
controlled.
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The majority of our patients who develot
oped TB were middle-aged (30–60 years),
similar to other studies. In the Indian study,
a majority of patients were above 40 years
of age [7]. In both the Korean [6] and
Japanese [9] studies, the prevalence was
particularly high in the age groups 40–50
years compared to the other age groups. In
our study, the prevalence of TB increased
progressively with duration of diabetes. The
highest prevalence was seen in those who
had been diagnosed with DM for more than
10 years. Comparative studies of type 1 DM
and type 2 DM have shown that the prevalt
lence of type 1 DM was 8-times higher in
TB patients than in the general population,
whereas the prevalence of type 2 DM was
similar [10]. TB patients with type 1 DM
have a more acute course of TB, rapid
progression, and formation of extensive lest
sions with multiple cavities [11]. There was
early clearance of bacilli and improvement
in cavities in type 1 DM compared with type
2 DM.
The reason for increased susceptibility
of diabetics to TB may be multifactorial.
Alveolar macrophages play a critical role
in eliminating mycobacterial infection in
collaboration with lymphocytes. Alveolar
macrophages have been found to be less actt
tivated in TB patients complicated with DM
which may contribute to increased susceptibt
bility [12]. In a study of 64 TB patients with
DM a higher depression of cellular immunt
nity was evidenced by fewer T lymphocytes
and their decreased capacity for blast-cell
transformation than those with TB alone
[13]. Differences in cytokine production
have also been observed. Interferon (IFN)gamma production by CD4+ T-cell was
reduced in patients with TB but those with
poor diabetic control produced significantly
less IFN-gamma than did patients with good
diabetic control. In a longitudinal study,
IFN-gamma production returned to normal
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by 6 months in patients with TB alone and
in well controlled diabetic TB patients but
remained suppressed in poorly controlled
diabetic TB patients [8]. Changes in pulmont
nary vasculature and alveolar oxygen presst
sure may also be contributory. Histological
features of disseminated microangiopathy
were observed in the lung preparations of
47 patients with destructive TB and DM
[14].
The presence of DM does not seem to
modify the presenting symptoms of pulmt
monary TB [2,3]. Fever with cough and
sputum remain the common presenting
features. Tuberculin reaction was found
to be similar [2]. Data on bacteriological
results are variable. Some studies showed
no difference in bacteriology results, bacilli
negative conversion rate or TB relapse rate
in diabetic patients [14]. Other studies have
shown that in diabetic patients the proportt
tion of smear positive cases was higher,
the culture-negative conversion period was
longer [15], relapse rates were higher [16]
and TB relapses were frequently associated
with resistant strains [14]. In a case–control
study from New York the relative risk of
multi-drug resistant TB was found to be
8.6 (confidence interval, 3.1 to 23.6) in the
diabetic group compared with the control
group [17]. In patients with pulmonary TB,
the most common underlying disease was
DM [15]. In an inner-city cohort, presence
of underlying illness (DM, chronic obstructt
tive pulmonary disease, renal failure) and
immunosuppression were important predictt
tors of survival for patients with pulmonary
TB [18].

Upper zone involvement and presence
of cavitations are typical features of active
pulmonary TB. In patients with DM and
other systemic diseases, chest radiograph
changes may be atypical. In our study,
lower lung field involvement was the most
frequent change, with upper and middle
changes less common. Bilateral changes
were present in half of the patients and an
associated effusion was present in onethird. In a comparative study of pulmonary
TB patients with and without DM, being a
diabetic was found to be the most important
factor determining lower lung field lesions
[1]. In a second study, lower lung field TB
was only seen in older diabetic patients
(above 40 years) and female sex [2]. Other
studies have, however, failed to show any
differences in localization of TB lesions
[3,19]. Cavitation was seen in only 26%
of our patients. A higher rate of multiple
cavitation has been reported in many studit
ies [1,2,19] but not in others [3]. Among
diabetics, patients with type 1 diabetes were
found to have more extensive lesions with
multiple cavities [11].
In conclusion, pulmonary TB may occur
more often among patients with diabetics
than those without, mostly between 40 and
70 years of age. Fever and cough are the
common presenting symptoms. Lower lung
field and bilateral or multi-lobar involvemt
ment is common. An associated effusion
may be present. The mortality rate was 10%
but was not associated with a particular
radiographic appearance.
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